Hemostemix Inc.
HMTXF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | -$0 | -$0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $402 | $3 | $0 | $3 |
| G&A Expenses | $1,186 | $426 | $955 | $1,532 |
| SG&A Expenses | $1,290 | $448 | $1,003 | $1,636 |
| Sales & Mktg Exp. | $104 | $22 | $49 | $104 |
| Other Operating Expenses | $66 | $31 | $32 | $66 |
| Operating Expenses | $1,758 | $482 | $1,035 | $1,705 |
| Operating Income | -$1,262 | -$482 | -$1,035 | -$1,705 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $905 | $174 | -$249 | -$597 |
| Pre-Tax Income | -$357 | -$308 | -$1,285 | -$2,302 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$357 | -$308 | -$1,285 | -$2,302 |
| % Margin | – | – | – | – |
| EPS | -0.002 | -0.002 | -0.014 | -0.026 |
| % Growth | -14.3% | 84.4% | 48.1% | – |
| EPS Diluted | -0.002 | -0.002 | -0.014 | -0.024 |
| Weighted Avg Shares Out | 146,474 | 146,474 | 95,059 | 87,122 |
| Weighted Avg Shares Out Dil | 146,474 | 146,474 | 95,059 | 95,059 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $139 | $173 | $166 | $163 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$305 | -$135 | -$1,118 | -$1,844 |
| % Margin | – | – | – | – |